Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roos

Showing results (451-460 of 543) with videos related to

Pageof 55
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patientsJ W Stroomer, J C Roos, M Sproll, et al.
Revue Neurologique|October 15, 2024
Migraine treatment: Position paper of the French Headache SocietyX Moisset, G Demarquay, S de Gaalon, et al.
Urologia Internationalis|October 3, 2021
The Impact of Preoperative Double-J Stent on Perioperative Complications, Recurrence, and Quality of Life in Adult Patients Undergoing PyeloplastyMike Wenzel, Benedikt Hoeh, Marieke J Krimphove, et al.
Human Brain Mapping|August 21, 2014
Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up studyOmar F F Odish, Annette A van den Berg-Huysmans, Simon J A van den Bogaard, et al.
Biological Psychiatry|November 28, 2017
Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic GenesPeter McColgan, Sarah Gregory, Kiran K Seunarine, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1Yi Wang, Olga Roche, Chaoying Xu, et al.
Neuroimage. Clinical|July 24, 2018
Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up studyVerena Baake, Emma M Coppen, Erik van Duijn, et al.
Frontiers in Oncology|August 16, 2021
Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical ProstatectomyPhilipp Mandel, Benedikt Hoeh, Felix Preisser, et al.
Journal of Neurology|October 12, 2010
Early atrophy of pallidum and accumbens nucleus in Huntington's diseaseSimon J A van den Bogaard, Eve M Dumas, Tanka P Acharya, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2017
Design optimization for clinical trials in early-stage manifest Huntington's diseaseChris Frost, Amy Mulick, Rachael I Scahill, et al.
Pageof 55

Showing results (451-460 of 543) with videos related to

Sort By:
Pageof 55
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patientsJ W Stroomer, J C Roos, M Sproll, et al.
Revue Neurologique|October 15, 2024
Migraine treatment: Position paper of the French Headache SocietyX Moisset, G Demarquay, S de Gaalon, et al.
Urologia Internationalis|October 3, 2021
The Impact of Preoperative Double-J Stent on Perioperative Complications, Recurrence, and Quality of Life in Adult Patients Undergoing PyeloplastyMike Wenzel, Benedikt Hoeh, Marieke J Krimphove, et al.
Human Brain Mapping|August 21, 2014
Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up studyOmar F F Odish, Annette A van den Berg-Huysmans, Simon J A van den Bogaard, et al.
Biological Psychiatry|November 28, 2017
Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic GenesPeter McColgan, Sarah Gregory, Kiran K Seunarine, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1Yi Wang, Olga Roche, Chaoying Xu, et al.
Neuroimage. Clinical|July 24, 2018
Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up studyVerena Baake, Emma M Coppen, Erik van Duijn, et al.
Frontiers in Oncology|August 16, 2021
Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical ProstatectomyPhilipp Mandel, Benedikt Hoeh, Felix Preisser, et al.
Journal of Neurology|October 12, 2010
Early atrophy of pallidum and accumbens nucleus in Huntington's diseaseSimon J A van den Bogaard, Eve M Dumas, Tanka P Acharya, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2017
Design optimization for clinical trials in early-stage manifest Huntington's diseaseChris Frost, Amy Mulick, Rachael I Scahill, et al.
Pageof 55